• Epidemiology and risk factors
• 30 min
  1. Epidemiology of COPD

  • Dr. David Mannino
• 36 min
  2. COPD in never smokers

  • Dr. Sundeep Salvi
• 43 min
  3. Genetics of chronic obstructive pulmonary disease (COPD)

  • Prof. Martin Tobin
• Phenotypes of COPD
• 44 min
  4. COPD and asthma: similarities and differences

  • Prof. Peter Barnes
• Pathophysiology and mechanisms of COPD
• 43 min
  5. The pathology of chronic obstructive pulmonary disease

  • Prof. James Hogg
• 63 min
  6. The continuum of COPD: a physiological perspective

  • Prof. Denis O'Donnell
• 47 min
  7. Inflammatory and immune mechanisms in COPD

  • Prof. Peter Barnes
• 44 min
  8. Mechanisms of COPD exacerbations and relation to exacerbation therapy

  • Prof. Wisia Wedzicha
• 39 min
  9. Protease-antiprotease balance

  • Prof. Robert Stockley
• Therapy and management
• 42 min
  10. Updates in chronic obstructive pulmonary disease (COPD)

  • Dr. Omar S. Usmani
• 45 min
  11. Long-acting bronchodilators in COPD

  • Prof. Bart Celli
• 54 min
  12. Treatment of COPD exacerbations

  • Prof. Antonio Anzueto
• 25 min
  13. Pulmonary rehabilitation: history, promise and problems

  • Prof. Richard Casaburi
• 29 min
  14. Lung volume reduction: advances in COPD

  • Dr. Nick Hopkinson
• 35 min
  15. New pharmacological therapies for COPD

  • Prof. Peter Barnes
• 32 min
  16. The Salford lung study in COPD

  • Dr. Dave Leather
• COPD case studies
• 11 min
  17. COPD treatment case I: COPD with “bronchitis attacks”

  • Dr. Janwillem Kocks
• 13 min
  18. COPD treatment case II: COPD with asthma as child

  • Dr. Janwillem Kocks
• 12 min
  19. COPD treatment case III: COPD with pre-diabetes

  • Dr. Janwillem Kocks
• 48 min
  20. Tailoring care for advanced COPD

  • Prof. Wissam Chatila
• Archived Lectures *These may not cover the latest advances in the field
• 59 min
  21. Alpha-1 antitrypsin deficiency: state of the art

  • Dr. Jamie Stoller
• 34 min
  22. Oxidative stress in COPD

  • Prof. William MacNee
• 24 min
  23. Managing co-morbidity in COPD

  • Dr. John Hurst
• 40 min
  24. Clinical phenotypes of COPD

  • Prof. Jørgen Vestbo
• 27 min
  25. Pulmonary rehabilitation: focusing on rehabilitative exercise

  • Prof. Richard Casaburi
• 36 min
  26. Genetics of COPD

  • Prof. Ian Hall

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Hyperinflation
3. Lung volume reduction for COPD
4. Lung volume reduction surgery (LVRS)
5. LVRS vs. medical therapy
6. Changes in lung volumes post LVRS
7. Surgical mortality in practice is higher
8. The national emphysema treatment trial (NETT)
9. NETT - inclusion and exclusion
10. NETT - results
11. Kaplan-Meier estimates of death probability
12. NETT - initial results
13. LVRS after the NETT
14. Longer term outcomes of NETT
15. Patient selection for LVRS
16. Surgery for bullae
17. Operating volumes during exercise in bullectomy
18. Elective surgery for giant bullous emphysema
19. ATS / ERS COPD guidelines
20. Other methods of lung volume reduction
21. Bronchoscopic lung volume reduction
22. Valves
23. Successful lung volume reduction using valve (1)
24. Successful lung volume reduction using valve (2)
25. Change in endurance time after BLVR
26. Successful BLVR is associated with survival
27. The VENT trial (1)
28. The VENT trial (2)
29. Baseline characteristics - The VENT trial
30. Primary outcomes at 6 months - The VENT trial
31. Adverse events at 90 days - VENT study
32. Heterogeneity effects on response to treatment
33. VENT trial - summary
34. Spiration valves
35. Airway bypass (1)
36. Airway bypass- demonstration
37. CASSA report
38. Airway bypass (2)
39. EASE trial
40. EASE trail - methods and participants
41. EASE trail - peri-procedure safety
42. 6 month primary safety endpoint
43. Bronchoscopy review of exhale stents
44. Short-lived benefits for airway bypass
45. Airway bypass - improvement needed
46. Future approaches
47. Transpleural airway bypass 'spiracles'
48. Extrapulmonary airway bypass
49. Device - continual development
50. Lung volume reduction coil PneumRx inc (1)
51. Lung volume reduction coil PneumRx inc (2)
52. Biological lung volume reduction
53. Blood lung volume reduction
54. Bronchoscopic Thermal Vapor Ablation
55. Conclusion

Topics Covered

• Hyperinflation in COPD
• Lung volume reduction surgery (LVRS)
• Bullectomy
• Bronchoscopic techniques including valves, airway bypass, coils, steam and fibrin glue

Links

Series:

• Advances in Chronic Obstructive Pulmonary Disease (COPD)

Categories:

• Clinical Practice

Therapeutic Areas:

• Immunology & Inflammation
• Respiratory Diseases

Talk Citation

Publication History

• Published on July 31, 2012

Financial Disclosures

• Dr. Nick Hopkinson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.